Mainz Biomed N.V. (MYNZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,561 | -26,387 | -18,199 | -12,603 | -5,664 |
| Depreciation Amortization | 287 | 380 | 135 | 62 | 35 |
| Accounts receivable | 28 | -211 | -148 | -47 | -184 |
| Other Working Capital | -398 | 1,387 | -232 | 360 | -14 |
| Other Operating Activity | 984 | 10,061 | 8,387 | 5,771 | 3,069 |
| Operating Cash Flow | $-5,659 | $-14,770 | $-10,057 | $-6,457 | $-2,758 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -901 | -658 | -644 | -252 | -76 |
| Purchase Sale Intangibles | -500 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -500 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,401 | $-658 | $-644 | $-252 | $-76 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,283 | 24,248 | 24,248 | 24,248 | 24,248 |
| Other Financing Activity | -510 | -305 | -196 | -157 | -138 |
| Financing Cash Flow | $774 | $23,943 | $24,053 | $24,092 | $24,111 |
| Exchange Rate Effect | 3 | -101 | -73 | -103 | -30 |
| Beginning Cash Position | 17,142 | 8,728 | 8,728 | 8,728 | 8,728 |
| End Cash Position | 10,858 | 17,142 | 22,007 | 26,007 | 29,974 |
| Net Cash Flow | $-6,284 | $8,414 | $13,279 | $17,279 | $21,246 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,659 | -14,770 | -10,057 | -6,457 | -2,758 |
| Capital Expenditure | -901 | -659 | -644 | -252 | -76 |
| Free Cash Flow | -6,560 | -15,429 | -10,701 | -6,709 | -2,834 |